# Antoine Italiano

Source: https://onco.cc/people/antoine-italiano/  
OnCo record `antoine-italiano` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Bordeaux oncologist who led CABONE, the trial that showed cabozantinib shrinks or stabilises osteosarcoma and Ewing sarcoma after standard treatment has failed.

## Summary

Antoine Italiano leads early-phase trials and the sarcoma unit at Institut Bergonié in Bordeaux. He was first author of the 2020 Lancet Oncology report of CABONE, the French Sarcoma Group phase 2 trial in which cabozantinib produced responses and prolonged disease control in advanced Ewing sarcoma and osteosarcoma. He also leads the PROFILER and other molecular profiling programmes in France.

## Fields

- Kind: Person
- Last checked: 2026-09-18
- Tags: sarcoma; early-phase; trialist
- Role: Head of Early-Phase Trials and Sarcoma Unit, Institut Bergonié, Bordeaux
- Specialisms: Sarcoma; Early-phase trials; Precision oncology

## Connected records

- cancers: [Ewing sarcoma](https://onco.cc/cancers/ewing-sarcoma/), [Osteosarcoma](https://onco.cc/cancers/osteosarcoma/), [Sarcomas (soft tissue, bone, GIST)](https://onco.cc/cancers/sarcoma/)
- institutions: [Institut Bergonié](https://onco.cc/institutions/institut-bergonie/)
- trials: [CABONE](https://onco.cc/trials/cabone/)

---
JSON: https://onco.cc/api/v1/entities/antoine-italiano.json